Literature DB >> 2196384

Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.

K Partin1, H G Kräusslich, L Ehrlich, E Wimmer, C Carter.   

Abstract

Proteolytic processing of the gag/pol precursor by the human immunodeficiency virus type 1 proteinase is essential for the production of infectious viral particles. Although the sites of virus-specific cleavages have been determined, the primary amino acid sequences surrounding these sites are heterogeneous and the determinants that direct the cleavage specificity exhibited by human immunodeficiency virus type 1 proteinase remain largely undefined. We performed mutational analysis of the Tyr/Pro site, which produces the amino terminus of the viral capsid protein, and the Phe/Pro site, which produces the amino terminus of the proteinase. Mutations were made in a clone encoding a frameshift mutation that results in the expression of equimolar amounts of the substrate and proteinase in the form of a truncated gag/pol precursor. After single-amino-acid substitutions were made, their effects on proteolytic processing were examined by in vitro transcription and in vitro translation of the synthetic mRNA; translation products were then processed by exogenously added purified proteinase. Single-amino-acid substitutions yielded both substrates which were processed with wild-type efficiency and substrates on which processing was impaired. At the Tyr/Pro site in gag, processing was severely inhibited by substitutions within the P4, P2, P1, and P2' positions. The Phe/Pro site in pol, however, demonstrated far greater tolerance to amino acid substitution. These data suggest that the primary amino acid sequence around a scissile bond is more critical for cleavage of the Tyr/Pro site than the Phe/Pro site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196384      PMCID: PMC249689     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Retroviral proteinases. A second front against AIDS.

Authors:  T Blundell; L Pearl
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

2.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.

Authors:  A Wlodawer; M Miller; M Jaskólski; B K Sathyanarayana; E Baldwin; I T Weber; L M Selk; L Clawson; J Schneider; S B Kent
Journal:  Science       Date:  1989-08-11       Impact factor: 47.728

3.  Molecular modeling of the HIV-1 protease and its substrate binding site.

Authors:  I T Weber; M Miller; M Jaskólski; J Leis; A M Skalka; A Wlodawer
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

4.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.

Authors:  H G Göttlinger; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.

Authors:  T D Meek; D M Lambert; G B Dreyer; T J Carr; T A Tomaszek; M L Moore; J E Strickler; C Debouck; L J Hyland; T J Matthews
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

6.  Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors.

Authors:  G B Dreyer; B W Metcalf; T A Tomaszek; T J Carr; A C Chandler; L Hyland; S A Fakhoury; V W Magaard; M L Moore; J E Strickler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.

Authors:  H G Kräusslich; R H Ingraham; M T Skoog; E Wimmer; P V Pallai; C A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

8.  Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.

Authors:  C Peng; B K Ho; T W Chang; N T Chang
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

9.  Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases.

Authors:  A D Richards; R Roberts; B M Dunn; M C Graves; J Kay
Journal:  FEBS Lett       Date:  1989-04-10       Impact factor: 4.124

10.  Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease.

Authors:  A G Tomasselli; J O Hui; T K Sawyer; D J Staples; D J FitzGerald; V K Chaudhary; I Pastan; R L Heinrikson
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.486

View more
  19 in total

1.  Local and spatial factors determining HIV-1 protease substrate recognition.

Authors:  S Hazebrouck; V Machtelinckx-Delmas; J J Kupiec; P Sonigo
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

2.  Assembly and processing of human immunodeficiency virus Gag mutants containing a partial replacement of the matrix domain by the viral protease domain.

Authors:  C T Wang; Y C Chou; C C Chiang
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1.

Authors:  K Partin; G Zybarth; L Ehrlich; M DeCrombrugghe; E Wimmer; C Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 4.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

5.  Identification of folding preferences of cleavage junctions of HIV-1 precursor proteins for regulation of cleavability.

Authors:  Hirotaka Ode; Masaru Yokoyama; Tadahito Kanda; Hironori Sato
Journal:  J Mol Model       Date:  2010-05-18       Impact factor: 1.810

6.  Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.

Authors:  Hsu-Chen Chiu; Szu-Yung Yao; Chin-Tien Wang
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.

Authors:  Michael E Abram; Michael A Parniak
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing.

Authors:  G Zybarth; C Carter
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.

Authors:  Steve C Pettit; Gavin J Henderson; Celia A Schiffer; Ronald Swanstrom
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.

Authors:  S C Pettit; M D Moody; R S Wehbie; A H Kaplan; P V Nantermet; C A Klein; R Swanstrom
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.